Patents Assigned to Protia, LLC
  • DEUTERIUM-ENRICHED PRAZOSIN
    Publication number: 20090062300
    Abstract: The present application describes deuterium-enriched prazosin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 25, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED VORICONAZOLE
    Publication number: 20090062310
    Abstract: The present application describes deuterium-enriched voriconazole, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED GABAPENTIN
    Publication number: 20090062392
    Abstract: The present application describes deuterium-enriched gabapentin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SILDENAFIL
    Publication number: 20090062298
    Abstract: The present application describes deuterium-enriched sildenafil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED CELECOXIB
    Publication number: 20090062364
    Abstract: The present application describes deuterium-enriched celecoxib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED AXITINIB
    Publication number: 20090062347
    Abstract: The present application describes deuterium-enriched axitinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 25, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED VARENICLINE
    Publication number: 20090062257
    Abstract: The present application describes deuterium-enriched varenicline, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 25, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ELETRIPTAN
    Publication number: 20090062367
    Abstract: The present application describes deuterium-enriched eletriptan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ZIPRASIDONE
    Publication number: 20090062303
    Abstract: The present application describes deuterium-enriched ziprasidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED OLANZAPINE
    Publication number: 20090005366
    Abstract: The present application describes deuterium-enriched olanzapine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 19, 2007
    Publication date: January 1, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ESZOPICLONE
    Publication number: 20080318964
    Abstract: The present application describes deuterium-enriched eszopiclone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 19, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED OSELTAMIVIR
    Publication number: 20080319064
    Abstract: The present application describes deuterium-enriched oseltamivir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 20, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED CLOPIDOGREL
    Publication number: 20080319004
    Abstract: The present application describes deuterium-enriched clopidogrel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 19, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TENOFOVIR
    Publication number: 20080318904
    Abstract: The present application describes deuterium-enriched tenofovir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 20, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE
    Publication number: 20080318915
    Abstract: The present application describes deuterium-enriched fluticasone propionate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 20, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MONTELUKAST
    Publication number: 20080319007
    Abstract: The present application describes deuterium-enriched montelukast, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 21, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SALMETEROL
    Publication number: 20080319086
    Abstract: The present application describes deuterium-enriched salmeterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 20, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED EZETIMIBE
    Publication number: 20080318920
    Abstract: The present application describes deuterium-enriched ezetimibe, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 19, 2007
    Publication date: December 25, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TAMSULOSIN
    Publication number: 20080312328
    Abstract: The present application describes deuterium-enriched tamsulosin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 14, 2007
    Publication date: December 18, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ESCITALOPRAM
    Publication number: 20080312318
    Abstract: The present application describes deuterium-enriched escitalopram, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 14, 2007
    Publication date: December 18, 2008
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik